Bradley Musser

Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors

Systematic review or meta-analysis · Clinical Pharmacology & Therapeutics · 2009 · 29 citations

Leveraging a Clinical Phase Ib Proof-of-Concept Study for the GPR40 Agonist MK-8666 in Patients With Type 2 Diabetes for Model-Informed Phase II Dose Selection

Clinical and Translational Science · 2017 · 13 citations